Clinical Trial
[Comparison of the lipid-lowering agents clofibrate and bezafibrate in patients with hyperlipoproteinemias IIa and IIb]
[Article in
German]
- PMID: 7025475
Item in Clipboard
Clinical Trial
[Comparison of the lipid-lowering agents clofibrate and bezafibrate in patients with hyperlipoproteinemias IIa and IIb]
[Article in
German]
Z Gesamte Inn Med.
.
Abstract
The influence of clofibrate and benzafibrate on total serum cholesterol and triglyceride level was investigated in patients with primary hyperlipoproteinaemia type IIa (16 patients) and IIb (13 patients), following a double-blind protocol. A significant decrease of the triglyceride level in the blood serum was stated in patients with hyperlipoproteinaemia type IIb, treated by benzafibrate. From the results presented in this paper it seems that benzafibrate is especially suitable for the treatment of hyperlipoproteinaemias, characterized by hypertriglyceridaemia.
Similar articles
-
Clinical experience with bezafibrate.Artery. 1980;8(6):553-9. Artery. 1980. PMID: 7259534
-
[The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].Schweiz Med Wochenschr. 1980 Dec 6;110(49):1875-7. Schweiz Med Wochenschr. 1980. PMID: 7455660 German.
-
[Comparative double-blind investigation of bezafibrate and clofibrate in patients with primary hyperlipoproteinaemia].Wien Klin Wochenschr. 1980 Feb 1;92(3):95-101. Wien Klin Wochenschr. 1980. PMID: 6985560 Clinical Trial. German.
-
Effects of fibric acid derivatives on biliary lipid composition.Am J Med. 1987 Nov 27;83(5B):37-43. doi: 10.1016/0002-9343(87)90869-2. Am J Med. 1987. PMID: 3318452 Review.
-
Effect of fibric acid derivatives on blood lipid and lipoprotein levels.Am J Med. 1987 Nov 27;83(5B):44-9. doi: 10.1016/0002-9343(87)90870-9. Am J Med. 1987. PMID: 3318453 Review.